haylaavo

BAFNAPHARM

BAFNAPHARM · NSE · inactive
3.55
-0.15 (-4.05%)
as of 23 Aug 2019 close
Open
3.70
High
3.85
Low
3.55
Prev close
3.70
52w high
21.85
12 Sept 2018
52w low
3.55
23 Aug 2019
VWAP
3.71
Delivery %
—
n/a
Volume 4,503 · turnover ₹17,000 · NSE bhavcopy (official close) · history since 12 Nov 2012
Series
EQ
F&O
No
Status
Inactive since 02 Apr 2019

Source: NSE equity master · as of 01 Apr 2019

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 13:28 IST
  • 20 Aug 2019 17:23
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Company has fixed Record Date as August 27, 2019 for the purpose of determining the eligible equity shareholders whose equity shares shall stand reduced, pursuant to the Resolution Plan approved by the Hon��ble National Company Law Board Tribunal, Chennai Bench vide its Order dated 1st February, 2019 ("Approved Resolution Plan").

    PDF · -
  • 30 May 2019 15:37
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Company has fixed Book Closure from June 24, 2019 to June 27, 2019 for the purpose of AGM.

    PDF · -
  • 06 Sept 2018 11:27
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company shall remain closed from September 23, 2018 to September 29, 2018 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on September 29, 2018.

    PDF · -
  • 12 Sept 2017 17:34
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2017 to September 30, 2017 (both days inclusive) for the purpose of Annual General Meeting.

    PDF · -
  • 20 Mar 2017 07:52
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that Outcome of Warrant Allotment Committee Meeting held on 18.03.2017 as per the terms of the Offer Letter.

    PDF · -
  • 01 Sept 2016 16:43
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from September 22, 2016 to September 27, 2016 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on September 28, 2016.

    PDF · -
  • 01 Jul 2016 18:38
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange the Submission of Resolution passed at the Meeting of the board of directors and Calender of events approved by the Directors.

    PDF · -
  • 17 Jun 2016 19:15
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the meeting of the Board of Directors considered and approve the proposal for Allotment of Equity Shares of 10,00,000 to Promoters and 30,00,000 Equity Shares to External investors (Non-Promoter) under Preferential allotment basis through Postal Ballot Process.

    PDF · -
  • 09 Sept 2015 13:42
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2015 to September 29, 2015 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 29, 2015.

    PDF · -
  • 08 Aug 2014 15:40
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from September 06, 2014 to September 10, 2014 (Both Days inclusive) for the purpose of Annual General Meeting to be held September 10, 2014.

  • 05 Jul 2013 13:00
    Corporate action

    Bafna Pharmaceuticals Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from September 21, 2013 to September 30, 2013 (Both Days inclusive) for the purpose of payment of dividend and Annual General Meeting of the Company to be held on September 30, 2013.

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries